Search results
Results from the WOW.Com Content Network
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT, [3] headed by Jason Kelly. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology.
Things have gotten so bad for biotech company Ginkgo Bioworks Holdings (NYSE: DNA) that it recently had to do a 1-for-40 reverse stock split to keep its share price up and stay listed on the New ...
It has been difficult to be a shareholder of Ginkgo Bioworks (NYSE: DNA) over the past year. The stock has collapsed about 72% from its peak last summer. The company's cell engineering foundry is ...
To say that Ginkgo Bioworks' (NYSE: DNA) stock is in a bit of a rough patch doesn't quite capture it. With the price of its shares down by 81% in 2024 alone, many investors are likely wishing they ...
Knight co-founded Ginkgo Bioworks, a synthetic biology company. Ginkgo Bioworks went public in 2021. [5] References External links. Knight Lab; Current webpage at MIT ...
Ginkgo Bioworks (NYSE: DNA) is a cell engineering company serving a wide variety of industries from drugmakers to agriculture and materials. Through its foundry, the company programs cells at ...
Agapakis is now the Creative Director of the Boston-based biotechnology company Ginkgo Bioworks, known as "The Organism Company," which specializes in genetically engineering organisms like yeast and bacteria for a number of applications—from engineering perfumes and food to engineering solutions for more sustainable agriculture.
The company's highly publicized difficulties in bringing its projected products to market and financial issues drew comparisons to other biotechnology companies such as Theranos. [10] [2] In July 2022, Ginkgo Bioworks agreed to acquire Zymergen for $300 million in an all-stock deal. [29] On October 3, 2023, Zymergen filed for Chapter 11 ...